Completed
PREVEMCAImpact of a Pharmacist-anesthesiologist Collaboration During Anesthesia Consultation on Prevention of Perioperative Medication Errors of Patients in Programmed Surgery
What is being tested
Pluridisciplinary consultation
Other
Who is being recruted
Over 18 Years
+10 Eligibility Criteria
How is the trial designed
Other Study
Interventional
Study Start: February 2020
Summary
Principal SponsorCentre Hospitalier Universitaire de Nīmes
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner
Study start date: February 25, 2020
Actual date on which the first participant was enrolled.The investigators will evaluate the efficiency of a pharmacist-anesthesiologist collaboration in the anesthetic consultation in the prevention of medical errors perioperatively in patients undergoing scheduled surgery
Official TitleImpact of a Pharmacist-anesthesiologist Collaboration During Anesthesia Consultation on Prevention of Perioperative Medication Errors of Patients in Programmed Surgery
Principal SponsorCentre Hospitalier Universitaire de Nīmes
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
378 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Other Study
Some studies explore topics that don't fall into a specific category. These might include innovative research, new technologies, or emerging healthcare areas.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Criteria
Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
4 inclusion criteria required to participate
The patient must have given their free and informed consent
The patient must be a member or beneficiary of a health insurance plan
The patient has at least one chronic medication prescription (associated with a chronic illness)
The patient is hospitalized for a programmed surgery in the service of urology or digestive surgery at the CHU Nimes or orthopedic surgery in the CHU Montpellier or Toulouse
6 exclusion criteria prevent from participating
The subject is participating in an interventional study, or is in a period of exclusion determined by a previous study
The subject refuses to sign the consent
It is impossible to give the subject informed information
The patient is under safeguard of justice or state guardianship
Show More Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Treatment Groups
Study Objectives
One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 3 locations
Suspended
Suspended
CHU de Nimes
Nîmes, FranceSuspended
CHU de Toulouse
Toulouse, FranceCompleted3 Study Centers